Circulating miR-30b-5p Level in Plasma as a Potential Biomarker for Early Detection of Breast Cancer | ||||
| Benha Medical Journal | ||||
| Articles in Press, Accepted Manuscript, Available Online from 24 August 2024 PDF (220.63 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/bmfj.2024.294366.2091 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Amal E. Shafie1; Dina Saad Abdelmotaleb 2; Mai Ashraf Ramadan  3; Enas Sebaey Ahmad4
| ||||
| 1Clinical and Chemical Pathology Department, Faculty of Medicine, Benha University, Benha, Egypt | ||||
| 2Lecturer of Clinical and Chemical Pathology, Faculty of Medicine, Benha University | ||||
| 3Clinical and Chemical Pathology Department, Faculty of Medicine, Benha University, Benha, Egypt. | ||||
| 4Clinical and Chemical Pathology Department, Faculty of Medicine, Benha University, Egypt | ||||
| Abstract | ||||
| Purpose: We aimed to assess the rule of plasma miR-30b- 5P as a biomarker for early diagnosis of breast cancer (BrC). Patients and Methods: This case control study was conducted on 50 participants, females, newly diagnosed with breast cancer before receiving any treatment. Subjects were categorized into two groups: Group I (patient group): 35 adults, their age was (53.6 ± 12.20) years, are newly diagnosed BrC before any treatment and Group II (control group): 15 subjects, their age was (47.7 ± 9.59) years, apparently healthy matching age and sex with patients. Results: There is statistically significant difference regarding presence of lesions by Mammogram when compare cases with control (p < .001). And there is a significant elevation in the expression of miR - 30 b - 5p when comparing cases with control group (p < .001). Conclusion: Plasma miR-30b-5P can be used as a biomarker for early diagnosis of BrC. | ||||
| Keywords | ||||
| MiRNA-30b-5p; Biomarker; Breast Cancer; Mammography | ||||
|
Statistics Article View: 141 PDF Download: 116 |
||||
